Cellectar strengthens global ip position with phospholipid drug conjugate composition of matter patent in eurasia, australia, and mexico

New patent covers phospholipid-ether analogs combined with various small molecule chemotherapeutics and methods of use for pdcs™ new patent covers phospholipid-ether analogs combined with various small molecule chemotherapeutics and methods of use for pdcs™
CLRB Ratings Summary
CLRB Quant Ranking